Study of the Characteristics of Chronic Pain in Patients With Addiction
ADDICTALGO
Descriptive, Prospective Study of the Characteristics of Chronic Pain in Patients With Addiction to at Least One Substance
1 other identifier
observational
300
1 country
1
Brief Summary
It is described in the literature a higher prevalence of pain in patients with an addiction but there are few studies describing the pain profile of patients with use disorder. Pain has a very negative impact on the quality of life of opioid substituted patients. Improving knowledge on this point would make it possible to better guide specific care. The investigator proposes to conduct a single-center descriptive observational study using questionnaires, without changing the management of patients with chronic pain. The primary objective of the study is to determine the prevalence of chronic pain in patients with substance addiction hospitalized for addiction treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 10, 2022
CompletedFirst Submitted
Initial submission to the registry
July 11, 2023
CompletedFirst Posted
Study publicly available on registry
August 4, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2025
CompletedMay 11, 2025
May 1, 2025
2.2 years
July 11, 2023
May 7, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Prevalence of chronic pain in patients with substance addiction hospitalized for addiction treatment.
Percentage of patients presenting with pain for more than three months among patients hospitalized in an addiction service for the management of an addiction
During the hospitalization, maximum 1 month
Secondary Outcomes (8)
Pain intensity in the last 24 hours
During the hospitalization, maximum 1 month
Interference of pain on the quality of life
During the hospitalization, maximum 1 month
Localisation of pain
During the hospitalization, maximum 1 month
Describe the frequency of the two main psychiatric comorbidities of chronic pain: anxiety
During the hospitalization, maximum 1 month
Describe the frequency of the two main psychiatric comorbidities of chronic pain: depression
During the hospitalization, maximum 1 month
- +3 more secondary outcomes
Eligibility Criteria
Patients hospitalized in the addictology department of LORIENT Hospital, in full hospitalization or in a day hospital
You may qualify if:
- \> 18 years old
- Presence of addiction to at least one substance, based on DSM-5 criteria
- Hospitalized in the addiction service of LORIENT Hospital
- Knowing how to read and write French
- Not objecting to their participation in the study after informed information
You may not qualify if:
- Already included during a precedent hospitalization
- Adults subject to legal protection or deprived of their liberty.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Groupe Hospitalier Bretagne Sud
Lorient, 56100, France
Related Publications (5)
Rosenblum A, Joseph H, Fong C, Kipnis S, Cleland C, Portenoy RK. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA. 2003 May 14;289(18):2370-8. doi: 10.1001/jama.289.18.2370.
PMID: 12746360BACKGROUNDLusted A, Roerecke M, Goldner E, Rehm J, Fischer B. Prevalence of pain among nonmedical prescription opioid users in substance use treatment populations: systematic review and meta-analyses. Pain Physician. 2013 Nov-Dec;16(6):E671-84.
PMID: 24284850BACKGROUNDBreivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006 May;10(4):287-333. doi: 10.1016/j.ejpain.2005.06.009. Epub 2005 Aug 10.
PMID: 16095934BACKGROUNDVoon P, Greer AM, Amlani A, Newman C, Burmeister C, Buxton JA. Pain as a risk factor for substance use: a qualitative study of people who use drugs in British Columbia, Canada. Harm Reduct J. 2018 Jul 5;15(1):35. doi: 10.1186/s12954-018-0241-y.
PMID: 29976203BACKGROUNDLarson MJ, Paasche-Orlow M, Cheng DM, Lloyd-Travaglini C, Saitz R, Samet JH. Persistent pain is associated with substance use after detoxification: a prospective cohort analysis. Addiction. 2007 May;102(5):752-60. doi: 10.1111/j.1360-0443.2007.01759.x.
PMID: 17506152BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alexandre Cauchie, MD
GH Bretagne Sud
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 11, 2023
First Posted
August 4, 2023
Study Start
December 10, 2022
Primary Completion
March 1, 2025
Study Completion
March 1, 2025
Last Updated
May 11, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share